We have a new publication in the Journal of Clinical Investigation: J. H. Garcia, E. A. Akins, S. Jain, K. J. Wolf, J. Zhang, N. Choudhary, M. Lad, P. Shukla, S. Gill, W. Carson, L. Carette, A. Zheng, S. Kumar, and M. K. Aghi (2024). Multi-omic screening of invasive GBM cells in engineered biomaterials and patient biopsies reveals targetable transsulfuration pathway alterations. Journal of Clinical Investigation 134(3):e170397 (PDF)(Science Perspectives).